Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oklahoma for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oklahoma only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oklahoma (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Sanjaykumar Hapani (NPI 1952508533)

Field	Value
Entity Type	Individual
Organization	Sanjaykumar Hapani
Address	13301 N Meridian Ave
City	Edmond
State	OK
ZIP	73120
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	June 28, 2007

Payer Source	Total Paid
Medicare	$2M
Medicaid	$0

Key Findings

This provider is effectively a Medicare-only billing entity: total Medicare revenue is $2M and there is no Medicaid billing on file, so payer mix is dominated by Medicare with no recorded Medicaid activity. That concentration means analyses and network decisions should treat this profile as single‑payer for public programs.

Revenue is highly concentrated in three drug/infusion codes: the top 3 Medicare codes (J9271, J0897, J1437) account for 81.5% of the provider's Medicare revenue. In particular J9271 accounts for $1.1M (52.5% of Medicare revenue), with J0897 at $317.5K (15.6%) and J1437 at $272K (13.4%), indicating that a small set of high-cost injectable drugs drive the majority of billed dollars.

The service mix is consistent with an outpatient oncology/infusion practice: J9271 (pembrolizumab), J0897 (denosumab), and J1437 (ferric derisomaltose) are the top revenue drivers and represent immunotherapy, bone‑modifying therapy, and high‑volume IV iron administration respectively. Chemotherapy administration code 96413 is present ($49.2K, 2.4% of Medicare revenue) along with infusion administration codes (96365 $16.9K) and supportive labs (85025 $17.7K), showing a combined model of drug-centric revenue with accompanying E/M and procedural services.

J1437 is an extreme outlier nationally: it ranks #6 of 581 providers (99th percentile; extreme outlier), which positions this provider among the highest-volume administrators of ferric derisomaltose in the country. J0897 also ranks well above typical national volume at #373 of 10057 providers (96th percentile; notably above typical national volume), suggesting a regional or practice-level specialization in these infused therapies.

By contrast, J9271 (pembrolizumab) ranks #229 of 1841 providers (87th percentile; typical, unremarkable volume), indicating that while pembrolizumab drives the largest share of dollars ($1.1M), the provider’s pembrolizumab volume is not exceptional relative to national peers. At the same time, E/M coding shows very high relative volume for high‑complexity office visits: 99214 produced $191.9K and ranks #1031 of 479517 (100th percentile; extreme outlier), and 99205 ($24.8K) ranks #799 of 66257 (99th percentile; extreme outlier), which together suggest above‑average billing for higher‑level evaluation and management encounters.

Operationally, claim counts point to a high-throughput infusion operation: J9271 has 24.8K claims, J0897 has 17.6K claims, and J1437 has 16K claims, indicating substantial per‑code activity rather than isolated high-dollar events. That scale of repeated infusion claims implies consistent nursing/infusion capacity and medication handling as central operational requirements for the practice.

Outside the top three drugs, revenue is fragmented across many lower-dollar services and administration codes: examples include 96413 (535 claims, $49.2K), 96365 (384 claims, $16.9K), and 85025 (2.2K claims, $17.7K), each representing modest shares of total Medicare revenue. This pattern—very large dollar concentration in a few drug codes combined with numerous smaller E/M, infusion, and lab items—indicates limited revenue diversification beyond the core infusion drug business.

The provider has an established presence based on enrollment tenure: the NPI was enumerated on 2007-06-28 (~19 years ago), which supports interpretation of the current coding and volume pattern as the product of a long-standing practice rather than a newly formed operation. Tenure plus the observed high-volume infusion codes suggest an entrenched outpatient infusion/oncology service line in its market.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

29 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	24,800	$40	$1.1M
J0897	Injection, denosumab, 1 mg	17,640	$20	$317.5K
J1437	Injection, ferric derisomaltose, 10 mg	16,000	$20	$272K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	2,130	$90	$191.9K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	540	$90	$49.2K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	4,480	$10	$26.9K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	160	$160	$24.8K
85025	A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a…	2,210	$10	$17.7K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	380	$40	$16.9K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	200	$60	$12.2K

Showing 1–10 of 29

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 29 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oklahoma Distribution

Sanjaykumar Hapani — 10 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oklahoma

Full comparison — all codes billed, vs. state median

29 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	1	10	10,600	$40	$466.9K
J1437	1	10	10,000	$20	$160.6K
J0897	4	70	2,130	$20	$91.2K
96413	7	60	210	$90	$26.4K
J0885	1	10	4,480	$10	$25.9K
99214	14	5,560	130	$70	$18.4K
99223	1,335	1,550	50	$130	$9.6K
99213	1,261	5,450	80	$50	$8.7K
85025	11	350	110	$10	$7.4K
96365	9	80	60	$40	$6.9K

Showing 1–10 of 29

Related Providers

Other providers that share a Tax Identification Number (TIN) with Sanjaykumar Hapani, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Central Oklahoma American Indian Health Council, Inc.	OK	Federally Qualified Health Center (FQHC)	$0	$79.6M
Absentee Shawnee Tribal Health Authority, Inc.	OK	Multi-Specialty Clinic/Center	$0	$31.1M
Absentee Shawnee Tribal Health Authority, Inc.	OK	Multi-Specialty Clinic/Center	$0	$15.8M
Robert Reynolds	OK	Hematology & Oncology Physician	$1.1M	$0
Christine Codding	OK	Rheumatology Physician	$597.4K	$0
Ravikumar Vasireddy	OK	Hematology & Oncology Physician	$436.5K	$0
Archana Gautam	OK	Cardiovascular Disease Physician	$392.9K	$0
Wudeneh Zewdie	OK	Nephrology Physician	$386.3K	$0
James Stewart	OK	MOHS-Micrographic Surgery Physician	$386.2K	$0
Michael Robinson	OK	Family Medicine Physician	$328.1K	$0

Nearby Providers

Other providers in the same ZIP code as Sanjaykumar Hapani, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mercy Clinic Oklahoma Communities	OK	Family Medicine Physician	$0	$45.4M
Mercy Hospital Oklahoma City, Inc	OK	General Acute Care Hospital	$0	$14.2M
Osu Center For Health Sciences	OK	Clinic/Center	$0	$11.6M
The Perinatal Center, PLLC	OK	Maternal & Fetal Medicine Physician	$0	$7.6M
Oklahoma Spine Surgery Center	OK	Ambulatory Surgical Clinic/Center	$6.8M	$708.6K
Childrens Eye Care P L L C	OK	Ophthalmology Physician	$0	$5.8M
Marquis Labs, LLC	OK	Clinical Medical Laboratory	$718.2K	$4.8M
Beacon Pointe, LLC	OK	Community/Behavioral Health Agency	$0	$3.5M
Ohh Physicians, LLC	OK	Cardiovascular Disease Physician	$0	$3.4M
Caring Home Health Agency Inc	OK	Home Health Agency	$0	$2.8M

Sanjaykumar Hapani — Billing Profile & Reimbursement Data

Sign up for Sanjaykumar Hapani — Billing Profile & Reimbursement Data policy alerts

Sanjaykumar Hapani — Billing Profile & Reimbursement Data

Sign up for Sanjaykumar Hapani — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References